If You Invested $10,000 in Livongo Health’s IPO, This Is How Much Money You’d Have Now

Livongo Health (NASDAQ:LVGO) stands out as one of the stocks that have benefited tremendously from the COVID-19 pandemic this year. The company’s digital health platform helps individuals manage chronic conditions like diabetes and hypertension. With the pandemic increasing the need for remote health monitoring and personalized healthcare, Livongo was in the right place at the right time.

Some investors were also in the right place at the right time by buying Livongo shares at the company’s initial public offering last year. They’ve won big from the rise of the healthcare stock in 2020. Here’s how much you would have now if you’d invested $10,000 in Livongo Health’s IPO.

Smiling woman holding a smartphone with images of dollar signs over it.

Image source: Getty Images.

Counting the cash

If you’d been able to buy at Livongo’s IPO price of $28, an initial investment of $10,000 would have given you 357 shares. If we assume you didn’t buy partial shares, you would’ve had a

Read More

COMPASS PATHWAYS (NASDAQ:CMPS) IPO PROVES PSYCHEDELIC MEDICINE INVESTMENT THESIS

Compass Pathways IPO marks the first liquidity event for WPSS.

WPSS invested in Compass Pathway’s series B alongside Founders Fund and McQuade/Otsuka. Compass Pathways IPO marks the first liquidity event for WPSS.WPSS invested in Compass Pathway’s series B alongside Founders Fund and McQuade/Otsuka. Compass Pathways IPO marks the first liquidity event for WPSS.
WPSS invested in Compass Pathway’s series B alongside Founders Fund and McQuade/Otsuka. Compass Pathways IPO marks the first liquidity event for WPSS.
WPSS invested in Compass Pathway’s series B alongside Founders Fund and McQuade/Otsuka. Compass Pathways IPO marks the first liquidity event for WPSS.

New York City, Oct. 01, 2020 (GLOBE NEWSWIRE) — WPSS Investments, a pioneer biotech Venture Capital fund focused on brain health and psychedelic medicine, celebrates the successful IPO of its portfolio company Compass Pathways. 

On September 18th, 2020 Compass Pathways was listed (NASDAQ:CMPS, ISIN:US20451W1018), making it the first psychedelic company to be listed on a U.S. exchange. CMPS´s price per share has surged more than 100% since its initial listing price of 17USD, turning it into the most valuable and first unicorn psychedelic medicine company in the world.

Compass Pathways, was co-founded several years ago by

Read More

Sina Goes Private, JD Health To Pursue Hong Kong IPO

Key News

Asian equities rebounded following last week’s poor performance in what turned out to be a busy night on the news front. Hong Kong and Mainland China markets will be closed on Thursday and Friday. Hong Kong will reopen next Monday, while the Mainland reopens on Friday, October 9th. Over the weekend, China’s August Industrial Profits grew by +19.1% year over year versus July’s 19.6%, providing further evidence of China’s V-shaped economic recovery.

US District Court Judge Carl Nichols played governor, granting TikTok a stay of execution on Sunday. The ruling gives the company and its suitors time to work on a deal.

Meanwhile, real estate giant Evergrande (3333 HK) repeatedly denied that it is in financial duress, which led to a rebound of +20% in the company’s stock price today after hitting a low point on chatter last week that it is experiencing a crash crunch.

Read More

What IPO and Walmart deal mean for fast-growing Oak Street Health

Fortified by an initial public offering, Oak Street Health is moving into new markets and testing a less familiar business model as it navigates the COVID-19 pandemic.

The Chicago-based network of primary care clinics for people 65 and older, many of whom have complex medical and social needs, raised $352 million when it went public last month.

The initial public offering gives Oak Street the capital to execute its aggressive growth plan, which includes building new senior-focused centers across the country and piloting three Walmart-based clinics for patients of all ages. But the funds come with more intense, short-term scrutiny for the company, which has operated in the red since launching in 2012.

Now Oak Street will have to manage such pressure on top of controlling rising medical costs and improving health outcomes for high-risk patients during a public health crisis.

“At a time when primary care is struggling, our

Read More

If You Invested $10,000 in Guardant Health’s IPO, This Is How Much Money You’d Have Today

I was a little late to the party in buying Guardant Health (NASDAQ:GH). After watching the stock soar during the latter part of 2018 and the first half of 2019, I finally jumped in to scoop up shares in July of last year. I’m glad I did.

But do I regret missing out on investing in Guardant Health at its initial public offering (IPO)? Yep. If you didn’t get in on the IPO, you might already share the same regret (at the very least, you soon will). Here’s how much you’d have today if you had invested $10,000 in Guardant Health’s IPO.

Five increasingly higher stacks of coins with blocks spelling out IPO on the three highest stacks and a businessman holding a red line trending up in the background

Image source: Getty Images.

A huge winner

Some IPO stocks rise quickly but then the gains evaporate. Not Guardant Health. It’s been a huge winner since day one.

Guardant Health operated as a privately held company for roughly six years before listing its shares on the Nasdaq

Read More

Is This Hot IPO Stock a Better Buy Than Teladoc Health?

This year will be remembered for lots of things. The COVID-19 pandemic, of course. The wild stock market roller coaster ride. The most named tropical storms in history.

But 2020 will also be known as a great year for initial public offerings (IPOs).

While Snowflake‘s IPO has received the most attention, another company that’s a leader in a fast-growing market also recently went public. Telehealth services provider American Well (NYSE:AMWL) priced its IPO at $18 per share, higher than the $14 to $16 range that the company initially projected. The stock opened on Sept. 17 nearly 42% higher than its IPO price. 

It’s only natural for investors to compare Amwell with another telehealth star, Teladoc Health (NYSE:TDOC). But is the hot IPO stock actually a better buy than Teladoc?

Person holding a smartphone displaying a video call with a doctor.

Image source: Getty Images.

Striking similarities

Amwell and Teladoc certainly have a lot in common. They’ve both emerged as

Read More